Transtek Supports Diabetes Management with Connected Blood Glucose Monitoring Solutions

via PRLog
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
ZHONGSHAN, China - Nov. 20, 2026 - PRLog -- Diabetes management requires regular blood glucose monitoring to help patients and healthcare providers track glucose levels and make informed care decisions. With World Diabetes Day drawing attention to the global impact of diabetes each November, Transtek highlights its existing range of connected blood glucose monitoring devices and their role in remote patient monitoring (RPM) programs.

According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20–79 were living with diabetes in 2024. This figure is projected to reach 853 million by 2050. The IDF also estimates that 252 million adults with diabetes remain undiagnosed, highlighting the importance of greater awareness, early screening, and appropriate medical care.

For people living with diabetes, regular blood glucose measurements provide useful information for tracking glucose levels and reviewing how daily activities and treatment may affect them. For healthcare providers, obtaining these readings outside clinical settings can help extend monitoring beyond scheduled visits. However, collecting measurements and transferring them to healthcare teams can add steps to both patient routines and provider workflows.

To support these needs, Transtek offers cellular and Bluetooth-enabled blood glucose monitoring devices for different RPM deployment requirements.

The TeleRPM BGM Gen 1 Cellular Blood Glucose Monitor features built-in 4G connectivity and supports AT&T, T-Mobile, and Verizon networks. It automatically transmits glucose readings without requiring patients to pair the meter with a smartphone, install an app, or configure a Wi-Fi connection.

For Bluetooth-based deployments, the TeleRPM Bluetooth Blood Glucose Monitor connects to the TeleRPM AnyHub, which uses built-in 4G connectivity to transmit measurement results. This configuration allows healthcare providers to incorporate blood glucose monitoring into multi-device RPM programs.

The blood glucose monitoring solutions use single-layer, 8-electrode test strips with hematocrit correction across a range of 20%–70%. The meter requires a 0.8 μL blood sample and delivers results in approximately five seconds, supporting routine blood glucose testing.

In addition to its blood glucose monitoring devices, Transtek provides Device Management Dashboards and fulfillment services to support healthcare providers with device deployment and RPM operations.

As diabetes continues to affect a growing global population, reliable blood glucose monitoring remains an important part of disease management. Transtek continues to provide connected medical devices and supporting services for partners developing and managing RPM programs.

About Transtek

Founded in 2002, Transtek provides medical devices and solutions for remote patient monitoring, combining medical-grade devices, connectivity technology, Device Management Dashboards, and fulfillment services to support telehealth partners and healthcare providers.

Contact
Guangdong Transtek Medical Electronics Co., Ltd.
***@transtekcorp.com

Photos: (Click photo to enlarge)

Guangdong Transtek Medical Electronics Co.,Ltd. Logo Transtek Supports Diabetes Management


Source: Guangdong Transtek Medical Electronics Co., Ltd.

Read Full Story - Transtek Supports Diabetes Management with Connected Blood Glucose Monitoring Solutions | More news from this source

Press release distribution by PRLog
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article